2 unknown, 1 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Terminated 1 |
Follow Bellerophon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Nitric Oxide for Preventing Progression in COVID-19 Nitric Oxide - COVID-19 | Phase 2 | Terminated | Tufts Medical Center | 10 | 2020-05-12 | 2022-04-19 |
| Inhaled NO in IPF and COPD During 6 Minute Walk Test Inhaled nitric oxide - COPD, IPF | Phase 2 | Unknown | Rabin Medical Center | 100 | 2019-03-04 | 2019-12-26 |
| A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis iNO - Pulmonary Hypertension, Pulmonary Fibrosis | Phase 2 | Completed | Bellerophon | 17 | 2019-01-30 | 2022-08-10 |
| A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis INOpulse®, Placebo, Long Term Follow Up - Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Unknown | Bellerophon | 85 | 2017-12-29 | 2023-02-28 |
Hypertension, Pulmonary (2) · Pulmonary Fibrosis (2) · COVID-19 (1) · Pulmonary Disease, Chronic Obstructive (1) · Sarcoidosis (1) · Sarcoidosis, Pulmonary (1)
Nitric Oxide (1)
United States (3) · Israel (1)
Ashika Ahmed, MD (1) · Edward Parsley, DO (1) · Marvin Konstam, MD (1) · Mordechai Kramer, MD (1)